Multi-spanning membrane proteins are targets of half of all small molecule drugs but only 3 therapeutic monoclonal antibodies (MAbs).
Leading Expertise in Antibodies, Viruses & Membrane Proteins
Transformative Technologies for Solving Scientific Challenges
Your success is our priority. We work
hard to understand your needs, and we
strive to exceed your expectations.
Products, Services & Partnering Opportunities
Reporter Virus Particles and other tools to expedite vaccine and antibody development